Both Gemfibrozil and Restasis offer similar effectiveness, with differences in speed and duration of relief.

Restasis is gentler on the liver and kidneys, making it a safer long-term option for some patients.

Both drugs are low-risk for addiction when used properly, with minimal potential for misuse.

Gemfibrozil has a simple once-daily dose, making it easier to stick to a treatment routine.

Both drugs have some contraindications depending on individual health conditions, but neither has major restrictions.

Gemfibrozil is ideal for fast relief, ease of use, and lower addiction risk, making it best for acute symptoms.